Cytotoxic-T-lymphocyte-associated antigen 4 blockade abrogates protection by regulatory T cells in a mouse model of microbially induced innate immune-driven colitis

Infection and Immunity

Volumn 76, Issue 12, 2008, Pages 5834-5842

  Watanabe, Koichiro ^a,b   Rao, Varada P ^a   Poutahidis, Theofilos ^a,c   Rickman, Barry H ^a   Ohtani, Masahiro ^a   Xu, Shilu ^a   Rogers, Arlin B ^a   Ge, Zhongming ^a   Horwitz, Bruce H ^d   Fujioka, Toshio ^b   Erdman, Susan E ^a   Fox, James G ^a,e  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b OITA UNIVERSITY   (Japan)

^c ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e Massachusetts Institute of Technology Cambridge   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4 ANTIBODY; GAMMA INTERFERON; INTERLEUKIN 2; RAG2 PROTEIN; TRANSCRIPTION FACTOR FOXP3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CELL PROTECTION; COLITIS; COLON MUCOSA; CONTROLLED STUDY; DISEASE COURSE; HELICOBACTER HEPATICUS; HOMEOSTASIS; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INNATE IMMUNITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, CD; COLITIS; DNA-BINDING PROTEINS; HELICOBACTER HEPATICUS; IMMUNITY, INNATE; IMMUNOHISTOCHEMISTRY; INTERFERON-GAMMA; INTERLEUKIN-2; MICE; T-LYMPHOCYTES, REGULATORY;

EID: 57349143302     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.00542-08     Document Type: Article

References (29)

1. Burroughs, N. J., B. Miguel Paz Mendes de Oliveira, and A. Adrego Pinto. 2006. Regulatory T-cell adjustment of quorum growth thresholds and the control of local immune responses. J. Theor. Biol. 241:134-141.
2. + regulatory T lymphocytes inhibit microbially induced colon cancer in Rag2-deficient mice. Am. J. Pathol. 162:691-702.
3. + regulatory lymphocytes require interleukin 10 to interrupt colon carcinogenesis in mice. Cancer Res. 63:6042-6050.
4. Min/+ mice. Cancer Res. 65:3998-4004.
5. + regulatory cell activation and function by dendritic cells. Int. Immunol. 16:1769-1780.
6. Fox, J. G., F. E. Dewhirst, J. G. Tully, B. J. Paster, L. Yan, N. S. Taylor, M. J. Collins, P. L. Gorelick, and J. M. Ward. 1994. Helicobacter hepaticus sp. nov., a microaerophilic bacterium isolated from livers and intestinal mucosal scrapings from mice. J. Clin. Microbiol. 32:1238-1245.
7. + regulatory T-cell function. J. Exp. Med. 196:851-857.
8. Ge, Z., Y. Feng, M. T. Whary, P. R. Nambiar, S. Xu, V. Ng, N. S. Taylor, and J. G. Fox. 2005. Cytolethal distending toxin is essential for Helicobacter hepaticus olonization in outbred Swiss Webster mice. Infect. Immun. 73:3559-3567.
9. Granucci, F., S. Feau, V. Angeli, F. Trottein, and P. Ricciardi-Castagnoli. 2003. Early IL-2 production by mouse dendritic cells is the result of microbial-induced priming. J. Immunol. 170:5075-5081.
10. Greenberg, G. R. 2004. Antibiotics should be used as first-line therapy for Crohn's disease. Inflamm. Bowel Dis. 10:318-320.
11. + regulatory T cells exert in vitro suppressive activity independent of CTLA-4. Int. Immunol. 17:421-427.
12. Krummel, M. F., and J. P. Allison. 1996. CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J. Exp. Med. 183:2533-2540.
13. Ladefoged, K., L. K. Munck, F. Jorgensen, and P. Engel. 2005. Skip inflammation of the appendiceal orifice: a prospective endoscopic study. Scand. J. Gastroenterol. 40:1192-1196.
14. Linsley, P. S., J. L. Greene, P. Tan, J. Bradshaw, J. A. Ledbetter, C. Anasetti, and N. K. Damle. 1992. Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes. J. Exp. Med. 176:1595-1604.
15. + T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms. J. Exp. Med. 197:111-119.
16. high T cells in inflammatory bowel disease. Gastroenterology 128:1868-1878.
17. Orabona, C., U. Grohmann, M. L. Belladonna, F. Fallarino, C. Vacca, R. Bianchi, S. Bozza, C. Volpi, B. L. Salomon, M. C. Fioretti, L. Romani, and P. Puccetti. 2004. CD28 induces immunostimulatory signals in dendritic cells via CD80 and CD86. Nat. Immunol. 5:1134-1142.
18. + T lymphocytes. J. Immunol. 178:732-739.
19. Petras, R. E., S. H. Mir-Madjlessi, and R. G. Farmer. 1987. Crohn's disease and intestinal carcinoma. A report of 11 cases with emphasis on associated epithelial dysplasia. Gastroenterology 93:1307-1314.
20. Poutahidis, T., K. M. Haigis, V. P. Rao, P. R. Nambiar, C. L. Taylor, Z. Ge, K. Watanabe, A. Davidson, B. H. Horwitz, J. G. Fox, and S. E. Erdman. 2007. Rapid reversal of interleukin-6-dependent epithelial invasion in a mouse model of microbially induced colon carcinoma. Carcinogenesis 28:2614-2623.
21. + T cells regulate gastric inflammation and Helicobacter pylori colonization in vivo. Gastroenterology 131:525-537.
22. + regulatory T cells abrogates their function in vivo. J. Immunol. 177:4376-4383.
23. + regulatory cells that control intestinal inflammation. J. Exp. Med. 192:295-302.
24. Salomon, B., and J. A. Bluestone. 2001. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu. Rev. Immunol. 19:225-252.
25. Sartor, R. B. 2004. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology 126:1620-1633.
26. Ullman, T., V. Croog, N. Harpaz, D. Sachar, and S. Itzkowitz. 2003. Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis. Gastroenterology 125:1311-1319.
27. Velayos, F. S., E. V. Loftus, T. Jess, W. S. Harmsen, J. Bida, A. R. Zinsmeister, W. J. Tremaine, and W. J. Sandborn. 2006. Predictive and protective factors associated with colorectal cancer in ulcerative colitis: a case-control study. Gastroenterology 130:1941-1949.
28. von Freeden-Jeffry, U., N. Davidson, R. Wiler, M. Fort, S. Burdach, and R. Murray. 1998. IL-7 deficiency prevents development of a non-T cell non-B cell-mediated colitis. J. Immunol. 161:5673-5680.
29. + T-cell regulatory functions. J. Immunol. 178:271-279.